Much of the research on BPC-157 to date has been done in laboratory animals, but researchers are now using the findings to date to help direct further research into the ways BPC-157 may be beneficial for human subjects
Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L, Zagrean AM
It's also a cofactor for the glutathione-S-transferase enzyme family, part of the body's normal cellular processing pathways
Glutathione IV therapy is known to produce particularly successful results in treating patients who are recovering from conditions such as strokes, or those who are afflicted with hepatitis, neurodegenerative disorders such as Parkinsons disease, and other chronic illnesses
The lower the glutathione level, the greater the likelihood of cellular deterioration, disease risk and cellular death